Search research articles
Contact Us
Filters
Showing results (161-170 of 587) with videos related to
Page
of 59
Sort By:
IEEE Transactions on Computational Biology and Bioinformatics
|
September 16, 2025
Heterogeneous Covariates-Aware Pseudo Supervised Meta-Learning for Few-Shot Diabetes Classification
Lei Wang, Wei Liu, Deheng Cai, et al.
Journal of Clinical Epidemiology
|
September 16, 2025
GRADE notes 6: Three strategies to determine the clinically important thresholds for outcomes in evidence-based guideline development
Xiaomei Yao, Jun Xia, Marisa Deodat, et al.
Diabetes/Metabolism Research and Reviews
|
May 31, 2025
The Contributions of Risk Factor Modifications to the Reduction of Cardiovascular Risk in Patients With Antidiabetic Treatment: A Meta-Regression Analysis and Model-Based Analysis
Xingyun Zhu, Chu Lin, Zonglin Li, et al.
Nutrition & Metabolism
|
August 8, 2022
Sex- and body mass index-specific reference intervals for serum leptin: a population based study in China
Jiayu Cheng, Yingying Luo, Yufeng Li, et al.
Mediators of Inflammation
|
September 10, 2021
The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis
Suiyuan Hu, Chu Lin, Xiaoling Cai, et al.
Biomed Research International
|
October 28, 2015
Hypoglycaemia, Abnormal Lipids, and Cardiovascular Disease among Chinese with Type 2 Diabetes
Yijun Li, Yiming Mu, Qiuhe Ji, et al.
Advances in Therapy
|
March 26, 2015
Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trial
Linong Ji, Bernard Zinman, Sanjay Patel, et al.
Bone
|
November 4, 2019
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis
Fang Lv, Xiaoling Cai, Wenjia Yang, et al.
Journal of Medical Economics
|
January 22, 2019
Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetes
Xiaoling Cai, Lizheng Shi, Wenjia Yang, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 8, 2025
Age at menarche, type 2 diabetes, and heart failure: A Mendelian randomization study
Jiayu Cheng, Hengchi Yu, Zimo Pan, et al.
Page
of 59
Search research articles
Search
Showing results (161-170 of 587) with videos related to
Sort By:
Page
of 59
IEEE Transactions on Computational Biology and Bioinformatics
|
September 16, 2025
Heterogeneous Covariates-Aware Pseudo Supervised Meta-Learning for Few-Shot Diabetes Classification
Lei Wang, Wei Liu, Deheng Cai, et al.
Journal of Clinical Epidemiology
|
September 16, 2025
GRADE notes 6: Three strategies to determine the clinically important thresholds for outcomes in evidence-based guideline development
Xiaomei Yao, Jun Xia, Marisa Deodat, et al.
Diabetes/Metabolism Research and Reviews
|
May 31, 2025
The Contributions of Risk Factor Modifications to the Reduction of Cardiovascular Risk in Patients With Antidiabetic Treatment: A Meta-Regression Analysis and Model-Based Analysis
Xingyun Zhu, Chu Lin, Zonglin Li, et al.
Nutrition & Metabolism
|
August 8, 2022
Sex- and body mass index-specific reference intervals for serum leptin: a population based study in China
Jiayu Cheng, Yingying Luo, Yufeng Li, et al.
Mediators of Inflammation
|
September 10, 2021
The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis
Suiyuan Hu, Chu Lin, Xiaoling Cai, et al.
Biomed Research International
|
October 28, 2015
Hypoglycaemia, Abnormal Lipids, and Cardiovascular Disease among Chinese with Type 2 Diabetes
Yijun Li, Yiming Mu, Qiuhe Ji, et al.
Advances in Therapy
|
March 26, 2015
Efficacy and safety of linagliptin co-administered with low-dose metformin once daily versus high-dose metformin twice daily in treatment-naïve patients with type 2 diabetes: a double-blind randomized trial
Linong Ji, Bernard Zinman, Sanjay Patel, et al.
Bone
|
November 4, 2019
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis
Fang Lv, Xiaoling Cai, Wenjia Yang, et al.
Journal of Medical Economics
|
January 22, 2019
Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetes
Xiaoling Cai, Lizheng Shi, Wenjia Yang, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 8, 2025
Age at menarche, type 2 diabetes, and heart failure: A Mendelian randomization study
Jiayu Cheng, Hengchi Yu, Zimo Pan, et al.
Page
of 59